Skip to main content
SpringerLink
Log in

Evaluation of Mood and the Effect of Angiotensin-Converting Enzyme Inhibitors

  • Section 3: Quality of Life
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Tests used to evaluate the impact of drug therapies on mood and well-being need to be more sensitive than standard psychiatric tests, and specific procedures for the construction and validation of such instruments have been developed. Suitable questions are selected from an initial pool of possible test items and a questionnaire is formed. This undergoes a pretest procedure to eliminate any unclear or offensive questions and is then evaluated in a suitable group of patients for validity, responsiveness (i.e. sensitivity) and reproducibility.

Using tests developed in this way, it has been shown that the transfer of hypertensive patients from standard triple therapy to placebo is accompanied by an increase in perceived well-being. Subsequent treatment with enalapril produced a further small increase in wellbeing. These and other results indicate that although angiotensin-converting enzyme (ACE) inhibitors may not have positive mood elevating properties, they are beneficial in terms of quality of life during treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Callender JS, Hodsman GP, Hutcheson MJ, Lever AF, Robertson JIS. Mood changes during captopril therapy for hypertension. A double-blind pilot study. Hypertension 5: III-90–III-93, 1983

    CAS  Google Scholar 

  • Croog SH, Levine S, Testa MA, Brown B, Bulpitt CJ, et al. The effects of antihypertensive therapy on the quality of life. New England Journal of Medicine 314: 1657–1664, 1986

    Article  PubMed  CAS  Google Scholar 

  • Dahlöf B, Andrén L, Eggertsen R, Jern S, Svensson A, et al. Potentiation of the antihypertensive effect of enalapril by randomized addition of different doses of hydrochlorothiazide. Journal of Hypertension 3 (Suppl. 3): S483–S486, 1985

    PubMed  Google Scholar 

  • Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. Canadian Medical Association Journal 134: 889–895, 1986

    PubMed  CAS  Google Scholar 

  • Jern S. Assessment of psychic side-effects of antihypertensive drugs. Acta Medica Scandinavica Suppl. 693: 103–106, 1985

    CAS  Google Scholar 

  • Jern S. Quality of life and hypertension. In Hansson (Ed.) Hypertension Annual 1987, Gower Academic Journals, in press

  • Olajide D, Lader M. Psychotrophic effects of enalapril maleate in normal volunteers. Psychopharmacology 86: 374–376, 1985

    Article  PubMed  CAS  Google Scholar 

  • Wenger NK, Mattson ME, Furberg CD, Elinson J. Assessment of quality of life in clinical trials of cardiovascular therapies. Le Jacq Publishing Inc; New York, 1984

    Google Scholar 

  • Zubenko GS, Nixon RA. Mood-elevating effect of captopril in depressed patients. American Journal of Psychiatry 171: 110–111, 1984

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hypertension Section, Department of Clinical Physiology, Östra Hospital, University of Göteborg, S-416 85, Göteborg, Sweden

    Sverker Jern

Authors
  1. Sverker Jern
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jern, S. Evaluation of Mood and the Effect of Angiotensin-Converting Enzyme Inhibitors. Drugs 35 (Suppl 5), 86–88 (1988). https://doi.org/10.2165/00003495-198800355-00015

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198800355-00015

Keywords

Search

Navigation